CHURC1
gene geneOn this page
Also known as My015FLJ33064
Summary
CHURC1 (churchill domain containing 1, HGNC:20099) is a protein-coding gene on chromosome 14q23.3, encoding Protein Churchill (Q8WUH1). Transcriptional activator that mediates FGF signaling during neural development.
Predicted to enable zinc ion binding activity. Predicted to be involved in fibroblast growth factor receptor signaling pathway.
Source: NCBI Gene 91612 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 16 total
- MANE Select transcript:
NM_001386928
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20099 |
| Approved symbol | CHURC1 |
| Name | churchill domain containing 1 |
| Location | 14q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | My015, FLJ33064 |
| Ensembl gene | ENSG00000258289 |
| Ensembl biotype | protein_coding |
| OMIM | 608577 |
| Entrez | 91612 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 retained_intron
ENST00000547625, ENST00000548752, ENST00000549115, ENST00000551093, ENST00000551947, ENST00000552002, ENST00000556089, ENST00000607599, ENST00000882584, ENST00000927076, ENST00000927077
RefSeq mRNA: 3 — MANE Select: NM_001386928
NM_001204064, NM_001386928, NM_145165
CCDS: CCDS32101, CCDS55921, CCDS55922
Canonical transcript exons
ENST00000549115 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003544305 | 64926010 | 64926080 |
| ENSE00003574023 | 64923991 | 64924126 |
| ENSE00003696566 | 64914455 | 64914534 |
| ENSE00003696700 | 64932138 | 64935368 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 98.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 66.2178 / max 819.9124, expressed in 1824 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 140135 | 66.2178 | 1824 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 98.31 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.77 | gold quality |
| right coronary artery | UBERON:0001625 | 96.75 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.56 | gold quality |
| tibial artery | UBERON:0007610 | 96.41 | gold quality |
| popliteal artery | UBERON:0002250 | 96.40 | gold quality |
| upper arm skin | UBERON:0004263 | 96.21 | gold quality |
| left coronary artery | UBERON:0001626 | 96.17 | gold quality |
| monocyte | CL:0000576 | 96.07 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.94 | gold quality |
| coronary artery | UBERON:0001621 | 95.92 | gold quality |
| leukocyte | CL:0000738 | 95.90 | gold quality |
| aorta | UBERON:0000947 | 95.87 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.76 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 95.67 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 95.56 | gold quality |
| muscle of leg | UBERON:0001383 | 95.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 95.27 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 95.24 | gold quality |
| ascending aorta | UBERON:0001496 | 95.24 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.20 | gold quality |
| skin of hip | UBERON:0001554 | 95.19 | gold quality |
| endothelial cell | CL:0000115 | 94.86 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 94.83 | gold quality |
| superficial temporal artery | UBERON:0001614 | 94.47 | gold quality |
| visceral pleura | UBERON:0002401 | 94.47 | gold quality |
| muscle tissue | UBERON:0002385 | 94.44 | gold quality |
| vermiform appendix | UBERON:0001154 | 94.41 | gold quality |
| myocardium | UBERON:0002349 | 94.41 | gold quality |
| parietal pleura | UBERON:0002400 | 94.41 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
113 targeting CHURC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
Literature-anchored findings (GeneRIF, showing 2)
- Embryonic neural inducing factor churchill is not a DNA-binding zinc finger protein: solution structure reveals a solvent-exposed beta-sheet and zinc binuclear cluster (PMID:17610897)
- This is the first implication of chr14q23.2-23.3 in the etiology of autism and points to MTHFD1, PLEKHG3, and CHURC1 as potential candidate genes contributing to autism risk. (PMID:21360829)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | churc1 | ENSDARG00000010831 |
| mus_musculus | Churc1 | ENSMUSG00000090258 |
| rattus_norvegicus | Fntb | ENSRNOG00000007660 |
Protein
Protein identifiers
Protein Churchill — Q8WUH1 (reviewed: Q8WUH1)
All UniProt accessions (4): B7Z3N2, Q8WUH1, H0YHB4, H0YID9
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional activator that mediates FGF signaling during neural development. Plays a role in the regulation of cell movement. Does not bind DNA by itself.
Similarity. Belongs to the Churchill family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WUH1-4 | 4 | yes |
| Q8WUH1-1 | 1 | |
| Q8WUH1-2 | 2 | |
| Q8WUH1-3 | 3 |
RefSeq proteins (3): NP_001190993, NP_001373857, NP_660148 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009508 | Transcrpt_activator_Churchill | Family |
| IPR038543 | Churchill_sf | Homologous_superfamily |
Pfam: PF06573
UniProt features (27 total): binding site 12, strand 7, splice variant 4, turn 3, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2JOX | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WUH1-F1 | 93.79 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (12): 2; 71; 88; 91; 5; 30; 30; 33; 59; 61; 64; 66
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 115 (showing top):
WANG_LMO4_TARGETS_DN, GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR, GOBP_RESPONSE_TO_GROWTH_FACTOR, chr14q23, GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY, ZHENG_BOUND_BY_FOXP3, GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY, BANP_TARGET_GENES, CBX7_TARGET_GENES, DYRK1A_TARGET_GENES, ELF2_TARGET_GENES, HOXB6_TARGET_GENES, IRF5_TARGET_GENES, ZNF146_TARGET_GENES
GO Biological Process (3): fibroblast growth factor receptor signaling pathway (GO:0008543), positive regulation of DNA-templated transcription (GO:0045893), multicellular organism development (GO:0007275)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell surface receptor protein tyrosine kinase signaling pathway | 1 |
| cellular response to fibroblast growth factor stimulus | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| positive regulation of RNA biosynthetic process | 1 |
| multicellular organismal process | 1 |
| anatomical structure development | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
710 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CHURC1 | ZEB2 | O60315 | 797 |
| CHURC1 | SERPINA3 | P01011 | 412 |
| CHURC1 | PCDH17 | O14917 | 406 |
| CHURC1 | FCGBP | Q9Y6R7 | 404 |
| CHURC1 | NPTX2 | P47972 | 396 |
| CHURC1 | NPAS4 | Q8IUM7 | 395 |
| CHURC1 | HLA-DPA1 | P01905 | 389 |
| CHURC1 | C1QC | P02747 | 383 |
| CHURC1 | SIRAL2 | Q9NWS6 | 371 |
| CHURC1 | FNTB | P49356 | 370 |
| CHURC1 | CFAP68 | Q9H5F2 | 370 |
| CHURC1 | IGF1 | P01343 | 370 |
| CHURC1 | PLEKHG3 | A1L390 | 369 |
| CHURC1 | CIMAP1D | Q3SX64 | 355 |
| CHURC1 | MRPL43 | Q8N983 | 349 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARPC4 | ARPC1B | psi-mi:“MI:0914”(association) | 0.910 |
| ACTR3B | ARPC2 | psi-mi:“MI:0914”(association) | 0.670 |
| CHURC1 | ZNF581 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CHURC1 | ZBTB9 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SERTAD1 | CHURC1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ACTR2 | PPP1R12A | psi-mi:“MI:0914”(association) | 0.350 |
| ACTR3B | ARPC2 | psi-mi:“MI:0914”(association) | 0.350 |
| ACTR2 | psi-mi:“MI:0914”(association) | 0.350 | |
| ARPC3 | psi-mi:“MI:0914”(association) | 0.350 | |
| GOSR1 | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| CHURC1 | NMT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CHURC1 | ZNF581 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (28): CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), CHURC1 (Two-hybrid), CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), ARPC3 (Affinity Capture-MS), ACTR2 (Affinity Capture-MS), ARPC1A (Affinity Capture-MS), ARPC5 (Affinity Capture-MS), ACTR3 (Affinity Capture-MS), CHURC1 (Affinity Capture-MS), ACTR3B (Affinity Capture-MS), UBB (Affinity Capture-MS), GLRX (Affinity Capture-MS)
ESM2 similar proteins: A0L3X0, A0RMQ6, A1SYJ9, A1VAL0, A1VXN9, A4XJM8, A5G8U0, A5ILC5, A5N3K1, A6Q6S1, A8FJW4, A9BJ07, B0K1F3, B0K7H0, B0S2B9, B2TJY1, B2UZI1, B8DRV3, B8FEA3, B8FZ78, B8GPB9, B9DX85, B9MR65, C0H406, C0H410, O31798, O48425, O54311, P03769, P9WK08, P9WK09, Q24ML8, Q2HJG7, Q30P97, Q30X20, Q38490, Q3A127, Q3IJB4, Q5HX10, Q5R6Q5
Diamond homologs: Q2HJG7, Q5R6Q5, Q5U3N7, Q66JD9, Q6DG52, Q8WUH1, Q9DFZ3, Q9DFZ4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 13 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| Arp2/3 complex-mediated actin nucleation | 5 | 438.9× | 1e-11 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1036 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:64923989:A:AG | acceptor_gain | 1.0000 |
| 14:64923989:AG:A | acceptor_gain | 1.0000 |
| 14:64923990:G:A | acceptor_gain | 1.0000 |
| 14:64923990:G:GG | acceptor_gain | 1.0000 |
| 14:64923990:GGGT:G | acceptor_gain | 1.0000 |
| 14:64923990:GGGTA:G | acceptor_gain | 1.0000 |
| 14:64924122:TGATC:T | donor_gain | 1.0000 |
| 14:64924123:GATC:G | donor_gain | 1.0000 |
| 14:64924123:GATCG:G | donor_gain | 1.0000 |
| 14:64924124:ATC:A | donor_gain | 1.0000 |
| 14:64924125:TC:T | donor_gain | 1.0000 |
| 14:64924126:CG:C | donor_loss | 1.0000 |
| 14:64924127:G:A | donor_loss | 1.0000 |
| 14:64924127:G:GG | donor_gain | 1.0000 |
| 14:64924128:TAA:T | donor_loss | 1.0000 |
| 14:64930875:G:GT | donor_gain | 1.0000 |
| 14:64939834:TTCTC:T | acceptor_gain | 1.0000 |
| 14:64939836:CTC:C | acceptor_gain | 1.0000 |
| 14:64939838:CCTAG:C | acceptor_loss | 1.0000 |
| 14:64939839:C:CC | acceptor_gain | 1.0000 |
| 14:64939840:T:G | acceptor_loss | 1.0000 |
| 14:64942499:CCTCA:C | donor_loss | 1.0000 |
| 14:64942500:CTCA:C | donor_loss | 1.0000 |
| 14:64942501:TCAC:T | donor_loss | 1.0000 |
| 14:64942502:CA:C | donor_loss | 1.0000 |
| 14:64942503:ACCTG:A | donor_loss | 1.0000 |
| 14:64942504:CCTGA:C | donor_loss | 1.0000 |
| 14:64914533:GG:G | donor_gain | 0.9900 |
| 14:64914534:GG:G | donor_gain | 0.9900 |
| 14:64914535:G:GG | donor_gain | 0.9900 |
AlphaMissense
926 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:64924039:T:C | C57R | 0.999 |
| 14:64926015:T:C | C88R | 0.999 |
| 14:64926057:T:C | F102L | 0.999 |
| 14:64926059:C:A | F102L | 0.999 |
| 14:64926059:C:G | F102L | 0.999 |
| 14:64932153:T:C | C115R | 0.999 |
| 14:64932155:T:G | C115W | 0.999 |
| 14:64932162:T:C | C118R | 0.999 |
| 14:64932163:G:A | C118Y | 0.999 |
| 14:64932164:C:G | C118W | 0.999 |
| 14:64932165:G:C | G119R | 0.999 |
| 14:64932166:G:A | G119D | 0.999 |
| 14:64924029:C:A | N53K | 0.998 |
| 14:64924029:C:G | N53K | 0.998 |
| 14:64924039:T:A | C57S | 0.998 |
| 14:64924040:G:C | C57S | 0.998 |
| 14:64924048:T:C | C60R | 0.998 |
| 14:64926015:T:A | C88S | 0.998 |
| 14:64926016:G:C | C88S | 0.998 |
| 14:64926017:T:G | C88W | 0.998 |
| 14:64926039:G:C | A96P | 0.998 |
| 14:64926040:C:A | A96D | 0.998 |
| 14:64926045:C:G | H98D | 0.998 |
| 14:64932154:G:A | C115Y | 0.998 |
| 14:64932160:T:C | L117S | 0.998 |
| 14:64932162:T:A | C118S | 0.998 |
| 14:64932163:G:C | C118S | 0.998 |
| 14:64932163:G:T | C118F | 0.998 |
| 14:64932165:G:T | G119C | 0.998 |
| 14:64932166:G:T | G119V | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000405287 (14:64914216 C>T), RS1000469258 (14:64922533 G>A), RS1000488309 (14:64925833 G>A,T), RS1000641784 (14:64931629 A>G), RS1000837619 (14:64926142 C>A,G), RS1001099578 (14:64916805 C>T), RS1001254721 (14:64928897 A>G,T), RS1001441949 (14:64928760 C>G,T), RS1001459828 (14:64914870 A>G,T), RS1001566166 (14:64928287 G>A,T), RS1001863267 (14:64928180 G>A,T), RS1001899570 (14:64918400 C>G), RS1002089957 (14:64921994 G>A,C), RS1002111616 (14:64924863 T>C), RS1002258761 (14:64930199 C>G,T)
Disease associations
OMIM: gene MIM:608577 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003518_66 | Daytime sleep phenotypes | 4.000000e-06 |
| GCST004862_27 | Itch intensity from mosquito bite adjusted by bite size | 6.000000e-07 |
| GCST90002397_360 | Mean spheric corpuscular volume | 6.000000e-10 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs4902333 | Efficacy | 3 | methylphenidate | Attention Deficit Disorder with Hyperactivity |
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| Cocaine | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| uranyl acetate | increases expression | 1 |
| methylparaben | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Heroin | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Uranium | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.